Recurrent gene fusions are common in high-grade serous ovarian cancer.

被引：0
|
作者：
Lehtonen, Rainer [1 ]
Carpen, Olli [1 ]
Huhtinen, Kaisa [2 ]
Hynninen, Johanna [2 ]
Kaipio, Katja [2 ]
Lamminen, Tarja [2 ]
Cervera, Alejandra [1 ]
Hietanen, Sakari [2 ]
Grenman, Seija [2 ]
Hautaniemi, Sampsa [1 ]
机构：
[1] Univ Helsinki, Helsinki, Finland
[2] Univ Turku, Turku, Finland
来源：
CLINICAL CANCER RESEARCH | 2018年 / 24卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B48
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [1] Variance of HRD score from primary to recurrent in high-grade serous ovarian cancer.
    Chen, Xiaoxiang
    Ni, Jing
    Xu, Xia
    Guo, Wenwen
    Zhao, Qian
    Cheng, Xianzhong
    Zhou, Rui
    Gu, Hongyuan
    Chen, Chen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Credentialing ERalpha as target in high-grade serous ovarian cancer.
    Oesterreich, Steffi
    Anderson, Courtney L.
    Sikora, Matthew J.
    Boisen, Michelle M.
    Ma, Tianzhou
    Tseng, George
    Chandran, Uma
    Christie, Alec
    Park, Yongseok
    Luthra, Soumya
    Haluska, Paul
    Mantia-Smaldone, Gina
    Odunsi, Kunle
    McLean, Karen
    Lee, Adrian
    Ellshaev, Esther
    Edwards, Robert P.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 122 - 122
  • [3] Modeling the tumor microenvironment of high-grade serous ovarian cancer.
    Balkwill, Frances
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 22 - 22
  • [4] Molecular analysis of exceptional response in high-grade serous ovarian cancer.
    Garsed, Dale
    Pandey, Ahwan
    Fereday, Sian
    Alsop, Kathryn
    Wouters, Maartje
    Saner, Flurina
    Kennedy, Catherine
    Pearce, Celeste
    Pike, Malcolm
    Ramus, Susan
    Kobel, Martin
    deFazio, Anna
    Goode, Ellen
    Nelson, Brad
    Bowtell, David
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 17 - 18
  • [5] Genetic characterization of metastasis and prognosis in high-grade serous ovarian cancer.
    Kotnik, Emilee N.
    Spies, Nicholas C.
    Li, Tiandao
    Inkman, Matthew
    Zhang, Jin
    Martins-Rodrigues, Fernanda
    Hagemann, Ian S.
    McCourt, Carolyn K.
    Thaker, Premal H.
    Hagemann, Andrea R.
    Powell, Matthew A.
    Mutch, David G.
    Maher, Christopher A.
    Miller, Christopher A.
    Fuh, Katherine C.
    CANCER RESEARCH, 2021, 81 (13)
  • [6] A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.
    Millstein, Joshua
    Budden, Timothy
    Anglesio, Michael
    Talhouk, Aline
    Beeghly-Fadiel, Alicia
    Berchuck, Andrew
    Chenevix-Trench, Georgia
    deFazio, Anna
    Fasching, Peter A.
    Gayther, Simon
    Garcia, Maria
    Goode, Ellen L.
    Henderson, Michelle
    Konecny, Gottfried E.
    Orsulic, Sandra
    Huntsman, David
    Bowtell, David
    Doherty, Jennifer
    Pharoah, Paul
    Ramus, Susan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Phenotypic and genomic characterization of intratumoral heterogeneity in high-grade serous ovarian cancer.
    Cunnea, Paula
    Curry, Ed
    Nixon, Katherine
    Wulandari, Ratri
    Thol, Kerstin
    Kwok, Chun Hei
    Ploski, Jennifer
    McNeish, Iain
    Christie, Elizabeth
    Bowtell, David
    Fotopoulou, Christina
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 42 - 42
  • [8] PAX8-directed nanotherapeutics for high-grade serous ovarian cancer.
    Chandrasekaran, Akshaya
    Ahmed, Mariam
    Holub, Nicole
    Wang, Wade
    Hammond, Paula T.
    Elias, Kevin M.
    CANCER RESEARCH, 2021, 81 (13)
  • [9] Drug resistance in end-stage high-grade serous ovarian cancer.
    Christie, Elizabeth L.
    Alsop, Kathryn
    Au-Yeung, George
    Pandey, Ahwan
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 17 - 17
  • [10] Singling out tumor heterogeneity and chemoresistance in high-grade serous ovarian cancer.
    Erkan, Erdogan Pekcan
    Dai, Jun
    Zhang, Kaiyang
    Kaipio, Katja
    Lamminen, Tarja
    Mansuri, Naziha
    Suominen, Lasse
    Alkodsi, Amjad
    Huhtinen, Kaisa
    Hietanen, Sakari
    Hynninen, Johanna
    Grenman, Seija
    Carpen, Olli
    Hautaniemi, Sampsa
    Vaharautio, Anna
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 59 - 59
12345